Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for re...
Orthometrix reported revenue of $2.41 million for fiscal year 2007, up 2.0% from fiscal year 2006, and net income of -$1.08 million. In Q3 2008 (the quarter ended September 30, 2008) revenue was $130,130, down 82.1% from a year before. Its market capitalization was $74,457 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2007; market data as of October 8, 2026.
No profile data available.